National Institutes of Health chief Francis Collins approved another 27 human embryonic stem cell lines for federal research funding Monday, but limited support to diabetes-related pancreatic cell experiments. The 27 Harvard University cell lines join 13 from Childrenâ??s Hospital Boston added earlier this month to a NIH stem cell registry.
Office of Strategic Communication